BI
STRO icon

BVF Inc’s Sutro Biopharma STRO Stock Holding History

BVF Inc’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.6M Hold
1,251,788
– – 1.06% 23
2026
Q1 		$31.2M Buy
+1,251,788
New +$22.6M 0.99% 26
2024
Q1 		– Sell
-334,795
Closed -$14.4M – 69
2023
Q4 		$14.4M Hold
334,795
– – 0.36% 43
2023
Q3 		$11.6M Hold
334,795
– – 0.31% 44
2023
Q2 		$15.6M Hold
334,795
– – 0.43% 39
2023
Q1 		$15.5M Hold
334,795
– – 0.57% 44
2022
Q4 		$27.1M Sell
334,795
-10,000
-3% -$695K 1.14% 31
2022
Q3 		$19.1M Hold
344,795
– – 0.79% 40
2022
Q2 		$18M Hold
344,795
– – 0.87% 34
2022
Q1 		$28.3M Buy
344,795
+252,280
+273% +$24M 1.13% 28
2021
Q4 		$13.8M Buy
92,515
+9,832
+12% +$1.76M 0.5% 47
2021
Q3 		$15.6M Hold
82,683
– – 0.61% 47
2021
Q2 		$15.4M Hold
82,683
– – 0.58% 44
2021
Q1 		$18.8M Sell
82,683
-102,733
-55% -$24.4M 0.71% 34
2020
Q4 		$40.3M Sell
185,416
-123,304
-40% -$20.4M 1.58% 22
2020
Q3 		$31M Buy
308,720
+71,881
+30% +$6.79M 1.69% 24
2020
Q2 		$18.4M Buy
236,839
+189,291
+398% +$18.2M 1.13% 27
2020
Q1 		$4.85M Buy
47,548
+13,028
+38% +$1.37M 0.45% 40
2019
Q4 		$3.8M Buy
34,520
+100
+0.3% +$10.3K 0.29% 47
2019
Q3 		$3.13M Buy
+34,420
New +$3.48M 0.33% 50

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

BVF Inc's STRO Position: Q2 2026 in Review

BVF Inc held its Sutro Biopharma (STRO) position steady in Q2 2026 at 1,251,788 shares worth $41.6M. The position accounts for 1.06% of the portfolio, ranked #23.

BVF Inc first reported a position in STRO in Q3 2019 and has held it in 20 quarters since. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • BVF Inc held 1,251,788 shares of Sutro Biopharma worth $41.6M as of Q2 2026.
  • BVF Inc left its Sutro Biopharma share count unchanged in Q2 2026.
  • Sutro Biopharma made up 1.06% of BVF Inc's portfolio in Q2 2026, its #23 holding.
  • BVF Inc first reported a position in Sutro Biopharma in Q3 2019 and has held it in 20 quarters since.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on BVF Inc's 13F filing for Q2 2026, filed 14 Aug 2026.